{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T20:54:26Z","timestamp":1757624066447,"version":"3.44.0"},"reference-count":17,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,7,6]],"date-time":"2023-07-06T00:00:00Z","timestamp":1688601600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Cardiology Cardiovascular Risk and Prevention"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1016\/j.ijcrp.2023.200196","type":"journal-article","created":{"date-parts":[[2023,7,10]],"date-time":"2023-07-10T13:18:26Z","timestamp":1688995106000},"page":"200196","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Trends of antihypertensive use among patients with cancer and hypertension in the United States 2002\u20132019"],"prefix":"10.1016","volume":"18","author":[{"given":"Harshith","family":"Thyagaturu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bandar","family":"Alyami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7321-0100","authenticated-orcid":false,"given":"Nicholas","family":"Roma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karthik","family":"Gonuguntla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gayatri","family":"Bondi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brijesh","family":"Patel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"20","key":"10.1016\/j.ijcrp.2023.200196_bib1","doi-asserted-by":"crossref","first-page":"2441","DOI":"10.1001\/jama.291.20.2441","article-title":"Prognostic importance of comorbidity in a hospital-based cancer registry","volume":"291","author":"Piccirillo","year":"2004","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.ijcrp.2023.200196_bib2","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.mayocpiqo.2021.05.005","article-title":"Cancer mortality rates increasing vs cardiovascular disease mortality decreasing in the world: future implications","volume":"5","author":"ReFaey","year":"2021","journal-title":"Mayo Clin. Proc. Innov. Qual. Outcomes"},{"issue":"1","key":"10.1016\/j.ijcrp.2023.200196_bib3","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1001\/jamacardio.2016.3841","article-title":"A population-based study of cardiovascular mortality following early-stage breast cancer","volume":"2","author":"Abdel-Qadir","year":"2017","journal-title":"JAMA Cardiol."},{"issue":"5","key":"10.1016\/j.ijcrp.2023.200196_bib4","first-page":"363","article-title":"Cancer treatment and survivorship statistics","volume":"69","author":"Miller","year":"2019","journal-title":"Ca - Cancer J. Clin."},{"key":"10.1016\/j.ijcrp.2023.200196_bib5","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/379252","article-title":"Incidence of new-onset hypertension in cancer patients: a retrospective cohort study","volume":"2013","author":"Fraeman","year":"2013","journal-title":"Int. J. Hypertens."},{"key":"10.1016\/j.ijcrp.2023.200196_bib7","first-page":"1053","article-title":"Diabetes, hypertension, and cardiovascular disease","volume":"37","author":"Sowers","year":"2001","journal-title":"AHA"},{"issue":"17","key":"10.1016\/j.ijcrp.2023.200196_bib8","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1161\/CIRCULATIONAHA.112.096156","article-title":"Trends in antihypertensive medication use and blood pressure control among United States adults with hypertension: the National Health and Nutrition Examination Survey, 2001 to 2010","volume":"126","author":"Gu","year":"2012","journal-title":"Circulation"},{"issue":"19","key":"10.1016\/j.ijcrp.2023.200196_bib9","doi-asserted-by":"crossref","first-page":"e127","DOI":"10.1016\/j.jacc.2017.11.006","volume":"71","author":"Whelton","year":"2017","journal-title":"J. Am. Coll. Cardiol."},{"issue":"23","key":"10.1016\/j.ijcrp.2023.200196_bib10","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1056\/NEJM198706043162301","article-title":"Effects of enalapril on mortality in severe congestive heart failure. Results of the cooperative North Scandinavian enalapril survival study (CONSENSUS)","volume":"316","year":"1987","journal-title":"N. Engl. J. Med."},{"issue":"8","key":"10.1016\/j.ijcrp.2023.200196_bib11","doi-asserted-by":"crossref","first-page":"2421","DOI":"10.2337\/diacare.26.8.2421","article-title":"ACE inhibitors improve diabetic nephropathy through suppression of renal MCP-1","volume":"26","author":"Amann","year":"2003","journal-title":"Diabetes Care"},{"issue":"23","key":"10.1016\/j.ijcrp.2023.200196_bib12","doi-asserted-by":"crossref","first-page":"2474","DOI":"10.1161\/CIRCULATIONAHA.106.635144","article-title":"Prevention of high-dose chemotherapy\u2013induced cardiotoxicity in high-risk patients by angiotensin-converting enzyme inhibition","volume":"114","author":"Cardinale","year":"2006","journal-title":"Circulation"},{"issue":"22","key":"10.1016\/j.ijcrp.2023.200196_bib13","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1056\/NEJM200105313442201","article-title":"Carvedilol prospective randomized cumulative survival study group. Effect of carvedilol on survival in severe chronic heart failure","volume":"344","author":"Packer","year":"2001","journal-title":"N. Engl. J. Med."},{"issue":"8","key":"10.1016\/j.ijcrp.2023.200196_bib14","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1056\/NEJM199808203390801","article-title":"Effect of beta-blockade on mortality among high-risk and low-risk patients after myocardial infarction","volume":"339","author":"Gottlieb","year":"1998","journal-title":"N. Engl. J. Med."},{"issue":"6","key":"10.1016\/j.ijcrp.2023.200196_bib15","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1161\/HYP.0000000000000066","volume":"71","author":"Whelton","year":"2017","journal-title":"Hypertension"},{"issue":"17","key":"10.1016\/j.ijcrp.2023.200196_bib16","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1001\/jama.2015.13766","article-title":"Trends in prescription drug use among adults in the United States from 1999-2012","volume":"314","author":"Kantor","year":"2015","journal-title":"JAMA"},{"issue":"11","key":"10.1016\/j.ijcrp.2023.200196_bib17","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.117.006986","volume":"6","author":"MacDonald","year":"2017","journal-title":"J. Am. Heart Assoc."},{"issue":"5","key":"10.1016\/j.ijcrp.2023.200196_bib18","first-page":"434","article-title":"Hypertension due to antiangiogenic cancer therapy with vascular endothelial growth factor inhibitors: understanding and managing a new syndrome","volume":"30","author":"Small","year":"2014","journal-title":"Can. J. Cardiol."}],"container-title":["International Journal of Cardiology Cardiovascular Risk and Prevention"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772487523000296?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772487523000296?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T10:57:03Z","timestamp":1757415423000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2772487523000296"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":17,"alternative-id":["S2772487523000296"],"URL":"https:\/\/doi.org\/10.1016\/j.ijcrp.2023.200196","relation":{},"ISSN":["2772-4875"],"issn-type":[{"type":"print","value":"2772-4875"}],"subject":[],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Trends of antihypertensive use among patients with cancer and hypertension in the United States 2002\u20132019","name":"articletitle","label":"Article Title"},{"value":"International Journal of Cardiology Cardiovascular Risk and Prevention","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijcrp.2023.200196","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"200196"}}